FDA panel supports rollout of tweaked booster shots from Moderna, Pfizer this fall
Jun 29, 2022
The advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations.
Education on approval process may increase acceptance of new RSV vaccines
Aug 14, 2023
Just 13% of respondents knew about the existence of an approved vaccine against RSV for older adults. Those educated on vaccine approval process or about potential severity of RSV may be more accepting.
Protection against SARS-CoV-2 wanes months after BNT162b2 vaccination
Oct 08, 2021
Declines were seen in humoral responses and effectiveness against SARS-CoV-2 infection within several months after the second dose of the Pfizer-BioNTech vaccine, also known as Comirnaty.
A second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus a single-dose campaign.
Vaccination offers extra protection after SARS-CoV-2 infection
Apr 06, 2022
Two studies show additional protection against reinfection and COVID-19-linked hospitalization with vaccination.
No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
Biden administration may back second booster shots for all adults
Jul 12, 2022
Expanding eligibility requirements for a fourth dose of the vaccine would require regulatory approval.
Myocarditis, myopericarditis risk up after SARS-CoV-2 vaccination
Dec 17, 2021
SARS-CoV-2 mRNA vaccination is associated with a significantly increased risk for myocarditis or myopericarditis for those receiving the mRNA-1273 (Moderna) vaccine and among females receiving the BNT162b2...
Health officials recommend spring COVID-19 booster for older adults
Feb 29, 2024
A second booster is appropriate as long as at least four months have passed since a person’s last COVID-19 shot.
Tetanus vaccine may be in short supply after company stops production
Feb 29, 2024
Sanofi plans to ramp up production of its version, but doctors should switch to the Tdap shot in the meantime.